Neo Ivy Capital Management Horizon Therapeutics Public LTD CO Transaction History

Neo Ivy Capital Management

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 15, 2022	SELL	$58.92 - $84.67 $120,609 - $173,319	-2,047 Reduced 80.94%	482 $30,000
Q2 2022 Aug 16, 2022	SELL	$79.4 - $116.36 $217,000 - $318,011	-2,733 Reduced 51.94%	2,529 $201,000
Q1 2022 May 16, 2022	BUY	$86.42 - $109.81 $449,729 - $571,451	5,204 Added 8972.41%	5,262 $554,000
Q4 2021 Feb 15, 2022	BUY	$98.56 - $119.91 $5,716 - $6,954	58 New	58 $6,000
Q2 2021 Aug 16, 2021	SELL	$86.24 - $95.92 $89,430 - $99,469	-1,037 Closed	0 $0

Q1 2021 Oct 07, 2021	BUY	$71.83 - $95.48 $74,487 - $99,012	1,037 New	1,037 $95,000
Q4 2020 Feb 16, 2021	SELL	$67.0 - $84.39 $12,529 - $15,780	-187 Closed	0 $0
Q3 2020 Nov 17, 2020	SELL	$55.23 - $79.93 $604,216 - $874,434	-10,940 Reduced 98.32%	187 $14,000
Q1 2020 May 15, 2020	BUY	$24.87 - $38.56 $276,728 - $429,057	11,127 New	11,127 $330,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Neo Ivy Capital Management, based on Form 13F filings with the SEC.

Stay updated on Neo Ivy Capital Management with notifications on news.